, John B. Gurdon 1, 3 & Tony Kouzarides 1, 12 Citrullination is the post-translational conversion of an arginine residue within a protein to the non-coded amino acid citrulline 1 . This modification leads to the loss of a positive charge and reduction in hydrogen-bonding ability. It is carried out by a small family of tissue-specific vertebrate enzymes called peptidylarginine deiminases (PADIs) 2 and is associated with the development of diverse pathological states such as autoimmunity, cancer, neurodegenerative disorders, prion diseases and thrombosis 2, 3 . Nevertheless, the physiological functions of citrullination remain ill-defined, although citrullination of core histones has been linked to transcriptional regulation and the DNA damage response [4] [5] [6] [7] [8] . PADI4 (also called PAD4 or PADV), the only PADI with a nuclear localization signal 9 , was previously shown to act in myeloid cells where it mediates profound chromatin decondensation during the innate immune response to infection 10 . Here we show that the expression and enzymatic activity of Padi4 are also induced under conditions of ground-state pluripotency and during reprogramming in mouse. Padi4 is part of the pluripotency transcriptional network, binding to regulatory elements of key stem-cell genes and activating their expression. Its inhibition lowers the percentage of pluripotent cells in the early mouse embryo and significantly reduces reprogramming efficiency. Using an unbiased proteomic approach we identify linker histone H1 variants, which are involved in the generation of compact chromatin 11 , as novel PADI4 substrates. Citrullination of a single arginine residue within the DNA-binding site of H1 results in its displacement from chromatin and global chromatin decondensation. Together, these results uncover a role for citrullination in the regulation of pluripotency and provide new mechanistic insights into how citrullination regulates chromatin compaction.
Pluripotent cells have the capacity to self-renew and differentiate into all somatic and germ-cell lineages and, hence, possess therapeutic potential for a multitude of medical conditions. Their generation by reprogramming of differentiated somatic cells has been achieved by nuclear transfer, cell fusion and transduction of transcription factors, such as Oct4 (also called Pou5f1), Sox2, Klf4 and c-Myc 12 . Pluripotent cells have a distinctly open chromatin structure that is essential for unrestricted developmental potential 13, 14 , and reprogramming involves an almost complete epigenetic resetting of somatic cells 13 . The ability of PADI4-mediated histone citrullination to induce chromatin decondensation in neutrophils 10 prompted us to ask whether it can have a role in pluripotency, where chromatin decondensation is also necessary. To investigate this we first assessed the expression of Padi4 in the mouse embryonic stem-cell line ES Oct4-GIP (ES), the mouse neural stem-cell line NSO4G and in induced pluripotent stem (iPS) cells derived from NSO4G (see Methods). Padi4 is expressed in pluripotent ES and iPS cells but not multipotent neural stem cells (Fig. 1a) . Culture of ES cells in 2i/LIF medium establishes a ground state of pluripotency 15 . This leads to the downregulation of lineage-specific markers and the upregulation of pluripotency factors, as well as rapid induction of Padi4 expression (Fig. 1b) . The pattern of Padi4 expression follows closely that of Nanog, an essential transcription factor for the transition to ground-state pluripotency 16 ( Fig. 1a, b) . Whereas other Padi genes are expressed in pluripotent cells, Padi4 is the only one for which expression clearly associates with naive pluripotency (Extended Data Fig. 1a, b) . Citrullination of histone H3 (H3Cit), a modification shown previously to be carried out specifically by PADI4 (ref. 17) , is detectable in ES and iPS cells (Extended Data Fig. 1c ), indicating that Padi4 is also enzymatically active. H3 and global citrullination are undetectable in NSO4G cells (Extended Data Fig. 1c, d) .
To determine the kinetics of Padi4 activation during the establishment of pluripotency, we examined RNA and protein samples collected daily during the course of reprogramming of NSO4G into iPS cells 16 . Padi4 is rapidly induced in NSO4G after transduction of reprogramming factors but only becomes active to citrullinate H3 after introduction of 2i/LIF, closely following the onset of Nanog expression (Fig. 1c) . These observations strongly suggested that Padi4 activity is associated with ground-state pluripotency and prompted us to examine whether Padi4 is part of the pluripotency transcriptional network.
First, we asked whether the reprogramming factors regulate Padi4 expression, using the ZHBTc4.1 and 2TS22C cell lines where Oct4 and Sox2, respectively, can be deleted acutely in response to doxycycline treatment (see Methods). Deletion of Oct4, but not Sox2, led to a decrease in Padi4 messenger RNA levels (Extended Data Fig. 1e ). Furthermore, whereas Oct4 and Klf4 occupy the Padi4 promoter in ES, but not NSO4G, cells, Sox2 is bound in both cell types (Extended Data Fig. 1f ). To understand the effects of Padi4 on transcriptional regulation in pluripotent cells, we analysed the transcriptome of ES cells upon overexpression of human PADI4 and inhibition of endogenous Padi4. Several key pluripotency genes are upregulated in response to PADI4 overexpression ( Table 2) , including Klf2, Tcl1, Tcfap2c and Kit. Tcl1 was previously identified as the only regulator of self-renewal upregulated in ground-state pluripotency 15 , and overexpression of Tcl1 or Tcfap2c positively influences reprogramming 18 . Gene Ontology (GO) analysis of this data set indicates an enrichment of genes involved in stemcell development and maintenance (Fig. 1e) . In addition, knockdown of Padi4 in mouse ES cells leads to decreased expression of Tcl1 and Nanog, which is rescued by exogenous expression of RNA interference (RNAi)-resistant human PADI4 ( Fig. 1f and Extended Data Fig. 2b, c) . These genes are under the control of PADI4 enzymatic activity, as treatment with the chemical inhibitor Cl-amidine, which disrupts citrullination by PADI4 (ref. 19 ), downregulates their expression (Fig. 1g) . Chromatin immunoprecipitation (ChIP) analysis indicated that H3Cit is present on regulatory regions of Tcl1 and Nanog in ES and iPS cells, but not NSO4G ( Fig. 1h and Extended Data Fig. 3a) . Accordingly, exogenously expressed human PADI4 localizes to and is enzymatically active on these regions, as well as regulatory regions of Klf2 and Kit in ES cells (Extended Data Fig. 3b, c) . In contrast to PADI4 overexpression, treatment of ES cells with Cl-amidine led to upregulation of differentiation markers such as Prickle1, Epha1 and Wnt8a and downregulation of pluripotency markers such as Klf5 (Extended Data Fig. 4a , b and Supplementary Table 3 ), in addition to Nanog and Tcl1 (Fig. 1g) . GO analysis of this data set indicated enrichment in genes involved in cell differentiation (Extended Data  Fig. 4c) . Pou5f1, Klf4, Sox2 and c-Myc were not affected by PADI4 modulation (Extended Data Fig. 2a and Supplementary Tables 2 and  3) . Cumulatively, the above results place Padi4 within the pluripotency transcriptional network, indicating that it acts downstream of some of the cardinal reprogramming factors to regulate a specific subset of pluripotency genes.
Prompted by the above observations, we investigated whether Padi4 is necessary for pluripotency, as assessed during reprogramming (Extended Data Fig. 5a ) and in the early stages of embryo development. NSO4G cells express a green fluorescent protein (GFP) reporter under the control of the Oct4 regulatory sequences, which is activated on acquisition of pluripotency 16 , allowing us to trace reprogrammed cells. Knockdown of Padi4 in NSO4G-derived pre-iPS cells impaired the ability of the cells to establish H3Cit upon switch to 2i/LIF medium and led to a clear reduction in reprogramming (Fig. 2a, Extended Data Fig. 5b -e and Supplementary Video 1). Consistent with this finding, levels of Tcl1 and Nanog were not elevated on reprogramming to the same extent as in control cells (Fig. 2b and Extended Data Fig. 5f ). Cl-amidine treatment led to a marked reduction of reprogramming efficiency and H3Cit ( Fig. 2c and Extended Data Fig. 5g-i) , indicating that the catalytic activity of Padi4 is important for the induction of pluripotency.
Padi4 expression and H3Cit are detected in the early embryo 20,21 and Padi4-null mice are born in lower numbers than would be expected by Mendelian inheritance 22 , indicating that Padi4 loss affects embryonic Error bars indicate standard error of the mean of three biological replicates. c, qRT-PCR for Padi4 and Nanog expression and H3Cit immunoblot during the course of reprogramming (see also Extended Data Fig. 5a ). Loading control: total histone H3. Representative of four experiments. d, Heat map of the genes regulated on human PADI4 (hPADI4) overexpression in mouse ES cells, as determined by microarray analysis. Displayed values are normalized log intensities, minus the mean expression of the gene across the four samples. Hierarchical clustering based on correlation. e, Gene Ontology for Biological Process (GOBP) analysis of the above microarray data set. P value is corrected for multiple testing using Benjamini and Hochberg false discovery rate (FDR). f, g, qRT-PCR for Tcl1 and Nanog expression in mouse ES cells after transient knockdown with Padi4 or control (ctrl) shRNAs, and overexpression of human PADI4 or control vector (pPB ctrl) (f), and after treatment with 200 mM Cl-amidine (g). Expression normalized to UbC. Error bars indicate standard error of the mean of three biological replicates. h, ChIP-qPCR for H3Cit on regulatory regions of Tcl1 and Nanog in mouse ES, NSO4G and iPS cells. Error bars indicate standard deviation of three technical qPCR replicates. Data are representative of three experiments. Asterisks denote difference with ES cells (a) or ES media (b), control (f, g) and between samples (f); NS, not significant; *P # 0.05, **P # 0.01, ***P # 0.001, ****P # 0.0001, by ANOVA (a, f) or t-test (b, g).
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development. To assess the role of Padi4 in early development, we cultured mouse embryos in Cl-amidine-containing medium from the 2-cell stage and throughout pre-implantation development (see Methods and Extended Data Fig. 6a-c) . Using 200 mM Cl-amidine resulted in a complete developmental arrest of the embryos at the 8-cell stage (Extended Data Fig. 6a ). We therefore used the maximum dose of Cl-amidine that reduced H3Cit (Extended Data Fig. 6b , c) but did not induce arrest (10 mM) . This led to a reduced percentage of pluripotent Nanog-positive epiblast cells and an increased percentage of differentiated trophectoderm cells at the blastocyst stage (Fig. 2d, e and Extended Data Fig. 6d, e) . Time-course analyses of the cleavage patterns and cell-fate decisions in early embryos showed that Cl-amidine increased the number of symmetric cell divisions at the expense of asymmetrical divisions at the 8-16-and 16-32-cell transitions (Fig. 2f, g ). This resulted in 16-cell-stage embryos with fewer inner cells (destined for pluripotency) and greater numbers of outer cells (destined for differentiation into trophectoderm; reviewed in ref. To elucidate the molecular mechanisms by which Padi4 regulates pluripotency, we aimed to identify PADI4 substrates in the chromatin fraction of mouse ES cells using stable isotope labelling of amino acids in cell culture (SILAC) (Fig. 3a and Extended Data Fig. 9a, b) . Among the identified PADI4 substrates were Atrx, Dnmt3b, Trim28 and variants of linker histone H1 (Fig. 3b- Table 4 ), all of which can have an impact on pluripotency. Histone H1 stabilizes the nucleosome and facilitates chromatin condensation, a state that is less permissive to processes that require access to the DNA, such as transcription 11 . The identified citrullinated H1 peptides correspond to, and are common between, variants H1.2, H1.3 and H1.4 (Fig. 3d, e) , whereas an additional peptide corresponds to the same residue in H1.5 (Extended Data Fig. 10a, b) . In ES cells, H1.2, H1.3 and H1.4 are required for chromatin compaction 25 , whereas their depletion leads to increased expression of pluripotency genes such as Nanog and stalls them in a self-renewal state with impaired differentiation capability 26 . Notably, H1 is more loosely bound to chromatin in ES cells than in differentiated cells 14 and its genomic localization in cancer cells was shown to anti-correlate with that of PADI4 (ref. 7) . Mass spectrometric analysis accounted for all arginine residues within H1 but indicated that Arg 54 is the only site citrullinated by PADI4 ( Fig. 3e and Extended Data Fig. 9c ). Indeed, we found that although H1.2 is citrullinated in ES cells (by endogenous Padi4, and significantly increased on PADI4 overexpression), it is refractory to modification when Arg 54 is mutated (Fig. 3f) . Similar results were obtained in in vitro citrullination assays (Extended Data Fig. 10c ). H1 Arg 54 lies within the globular domain of H1 (Extended Data Fig. 10d ), which is highly conserved among the linker histone family and is necessary for interaction with nucleosomal DNA 27, 28 . To test whether H1 Arg 54 is necessary for binding of H1 to nucleosomes, we mutated and assessed it in nucleosome-binding assays. Figure 3g shows that an R54A mutant, which mimics the charge change that accompanies citrullination, is impaired for nucleosome binding. An R54K mutant, which retains the positive charge, is impaired to a lesser extent (Fig. 3g) , indicating that H1R54 is important for electrostatic interactions between H1.2 and the nucleosome. The above results open up the possibility that PADI4 may affect chromatin compaction in pluripotent cells. To test this hypothesis, we first assessed whether citrullination by ectopic PADI4 can lead to decondensation of differentiated cell chromatin. Recombinant PADI4 was added to permeabilized and stabilized differentiated C2C12 mouse myoblast nuclei (Fig. 4a) . This protocol ensures stabilization of the nuclear component while allowing the free diffusion of non-chromatin-bound nuclear proteins into the extranuclear fraction, and their collection by washing. Incubation with active PADI4 
). Asterisks denote difference with control; *P # 0.05, **P # 0.01, ***P # 0.001, ****P # 0.0001.
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(Extended Data Fig. 10e , f) leads to the eviction of H1 from the chromatin and its diffusion out of the permeabilized nucleus (Fig. 4b) . The evicted H1 is citrullinated on Arg 54, as determined by mass spectrometry (Extended Data Fig. 10g , h). Consistent with this, PADI4-treated cells showed evidence of decondensed chromatin, as determined by nuclear swelling, diffuse 49,6-diamidino-2-phenylindole (DAPI) staining and increased sensitivity to micrococcal nuclease ( The work described here identifies citrullination of chromatin components by Padi4 as a feature of pluripotency ( Fig. 4g ), in addition to its previously described role in the myeloid lineage. One of the reasons for the restricted expression pattern of Padi4 may be the requirement for 
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an open chromatin state in these cell types. The selective expression characteristics and the inducible nature of the catalytic activity of Padi4 indicate that it is under tight spatial and temporal regulation, giving it a unique status among chromatin-modifying enzymes. As such, inappropriate Padi4 activity may have deleterious consequences, which may explain its activation in cancers of varying origin during progression to malignancy 29 . Indeed, citrullination is a common feature of several unrelated diseases, suggesting that strict regulation is probably a requirement for the physiological function of all PADIs. During review of this manuscript, a study suggested that PADI2, thought to be mainly cytoplasmic, can also citrullinate histones and lead to transcriptional activation 30 . This opens up the possibility that other PADIs may mediate nuclear events in specific contexts, including in pluripotent cells. Further research into the function and targets of PADIs is likely to illuminate the aetiology of several pathologies.
METHODS SUMMARY
Information regarding cell lines, antibodies, plasmids and chemical inhibitors used in this study, as well as detailed protocols for reprogramming and cell culture, overexpression and knockdown, gene expression analysis (qRT-PCR and microarray), chromatin immunoprecipitation, embryo collection, culture, immunofluorescence staining and analysis, immunoblot analysis, SILAC labelling, mass spectrometry and identification of citrullinated peptides and proteins, native purification of wild-type and mutant linker histone H1.2, H1-GFP and nucleosome pull-down assays, purification of recombinant PADI4-GST and in vitro deimination assays, treatment of permeabilized cells with recombinant PADI4, and micrococcal nuclease digestion are provided in the Methods.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 35 . The Gateway system was used to clone human PADI4 into the piggyBac vector using the following primers: PADI4_AttB1_F, 59-GGGGACAAGTTTGTA CAAAAAAGCAGGCTTCACCATGGCCCAGGGGACATTGATCCG-39; PADI4_ AttB2_R, 59-GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGGGCACC ATGTTCCACC-39.
pB-CAG-Ctrl or pB-CAG-hPADI4 vectors (1 mg) were transfected with piggyBac transposase (pPBase) expression vector, pCAGPBase (2 mg) , by nucleofection according to the manufacturer's instructions (Lonza). ES E14 cells constitutively expressing the hygromycin resistance gene and human PADI4 were selected and expanded in media containing 200 mg ml 21 hygromycin. Where applicable, ES cell lines were generated after selection with 1 mg ml 21 puromycin. Reprogramming. Reprogramming was performed as described previously 36, 37 . For retroviral supernatant preparation, 9 mg of pMXs-Oct4, pMX-Klf4 and pMXsc-Myc were transfected with FuGENE 6 into 1-2 3 10 6 Plat-E cells in separate 10 cm dishes. After 24 h incubation, the media was replaced with DMEM 1 10% FCS and penicillin/streptomycin. Virus-containing supernatants from Plat-E cultures were filtered through a 0.22-mm cellulose acetate filter, mixed in equal ratios, and 4 mg ml 21 polybrene was added. 2 ml of the final viral mix was then added to previously plated 1.2 3 10 5 NSO4G cells, in 6-well plates coated with gelatin. After 1 day, the media was replaced with NSO4G cell culture medium. After 3 days incubation, the media was changed to ES cell serum-containing media (see above). At this stage, pre-iPS colony formation was evident, but none of the colonies was positive for GFP expression (GFP 1 ). After 2 days and to complete reprogramming, medium was replaced with 2i/LIF. Cells were maintained in 2i/LIF for 8 days, with media change every 2 days. Oct4-GFP 1 colonies were counted at day 7 in 5-9 selected fields per well, either at the microscope or after time-lapse image acquisition on the Biostation CT (Nikon). The percentage of GFP 1 cells was determined by flow cytometry at day 8, using a Dako Cytomation CyAN ADP high-performance cytometer and Summit software, as described previously 36, 37 . Statistical significance was determined by two-tailed unpaired t-test. For the time course experiments, cells were collected with 350 ml RLT buffer (Qiagen) or 23 Laemmli buffer, from individual wells in consecutive days and after a PBS wash.
Cl-amidine (200 mM) was added at the time of media exchange to 2i/LIF and replenished every 2 days. For Padi4 knockdown experiments, pre-iPS cells were maintained in ES-cell-serum-containing media and cell lines were generated after transfection with lipofectamine 2000 with the Mission RNAi pLKO.1-puro vectors, containing either a non-targeting shRNA (SHC002) or mouse Padi4 targeting shRNAs TRCN000101833 (shRNA 3) or TRCN000101834 (shRNA 4). After puromycin selection, control and Padi4 knockdown pre-iPS cell lines were generated. Notably, puromycin treatment abolished all non-transfected pre-iPS cells, and control and shPadi4 pre-iPS cell lines were Oct4-GFP negative (Fig. 2a) . For reprogramming experiments, 1 3 10 5 cells were plated in individual wells (6-well plates) in triplicate and without puromycin, and media was changed to 2i/LIF after day 1. Cells were maintained in 2i/LIF for 8 days, with media change every 2 days, and assessed for Oct4-GFP as previously described. qRT-PCR primer design. GenBank and Ensembl cDNA sequences were used to design gene-specific primers in Primer 3 (ref. 38) or in the Universal ProbeLibrary Assay Design Center (Roche Applied Science). The specificity of PCR primers was determined via the in-Silico PCR (UCSC Genome Browser) and Primer-BLAST (NCBI) web-based tools. Oligonucleotides were obtained from Sigma. Primer sequences can be found in Supplementary Table 1 . Reverse transcription. Total RNA was isolated from ES cells, NSO4G and cells during reprogramming, using the RNeasy extraction kit with in-column DNase treatment (Qiagen). Total RNA was reverse transcribed with the High-Capacity cDNA Reverse Transcription kit for 1 h (Applied Biosystems). Samples were aliquoted equally into positive and negative (RT2) reactions. Before qPCR analysis, samples were diluted five-or tenfold with DNase/RNase free dH2O (Ambion). qPCR. qPCR reactions were performed in duplicate or triplicate for each sample. Each PCR reaction had a final volume of 10-20 ml and 2.5-5 ml of diluted cDNA or ChIP DNA. RT2 samples were assayed to discount genomic DNA amplification. Fast SYBR green Master Mix or TaqMan Fast Universal PCR Master Mix (Applied Biosystems) was used according to the manufacturer's instructions. A melting curve was obtained for each PCR product after each run, to confirm that the SYBR green signal corresponded to a unique and specific amplicon. Random PCR products were also run in a 2-3% agarose gel to verify the size of the amplicon. Standard curves were generated for each real-time PCR run using serial threefold dilutions of a sample containing the sequence of interest. Their plots were used to convert C T values (number of PCR cycles needed for a given template to be amplified to an established fluorescence threshold) into arbitrary quantities of initial template per sample. Expression levels were then obtained by dividing the quantity by the value of housekeeping genes, such as ubiquitin (UbC). UbC assays were run every time samples were frozen/thawed. Statistical analysis was performed in Prism 6 using one-way ANOVA analysis of variance with HolmSidak's multiple comparisons test or two-tailed unpaired t-test. Gene expression analysis. Mouse WG-6 Expression BeadChip microarrays (Illumina) were processed at the Cambridge Genomic Services, Department of Pathology, University of Cambridge. Three biological replicates were assayed for each condition. Illumina microarray probes were matched to gene identifiers according to the re-annotation of the microarray platform 39 . For both the PADI4 overexpression and the Cl-amidine inhibition experiments, normalization was performed using the lumi 40 R package. Limma 41 was used for differential expression analysis, with Benjamini-Hochberg (FDR) adjusted P-values ,0.05 considered significant. Gene ontology (GO) enrichment analysis was performed using GOstats 42 , and results adjusted for multiple testing using the Benjamini-Hochberg procedure (FDR). Immunoblot analysis. For immunoblot analysis, cell monolayers or pellets were re-suspended in 23 Laemmli buffer, incubated for 5 min at 95 uC and passed 10 times through a 21G needle to shear genomic DNA. In the case of trichloroacetic acid precipitated proteins, pellets were re-suspended in buffer and boiled as above. Proteins were separated by SDS-PAGE, transferred to nitrocellulose membrane (Millipore) using wet transfer and incubated in blocking solution (5% BSA in TBS containing 0.1% Tween) for 1 h at room temperature. Membranes were incubated with primary antibody at 4 uC overnight and appropriate HRP-conjugated secondary antibody for 2 h at room temperature. Membranes were then incubated for enhanced chemiluminescence (ECLH; GE Healthcare) and proteins were detected by exposure to X-ray film. Primary antibodies, diluted in blocking solution, were used against citrullinated histone H3 (anti-H3Cit, Abcam, ab5103 at 1:50,000 dilution), unmodified histone H3 (anti-H3, Abcam, ab10799 at 1:2,000), linker histone H1 (anti-H1, Santa Cruz Biotechnology, sc-34464 at 1:200), GFP (anti-GFP, Abcam, ab290 at 1:5,000) and Gapdh (anti-Gapdh, Abcam, ab9485 at 1:2,500). Citrulline-containing proteins were modified on the membrane and detected using the anti-modified citrulline detection kit (Millipore) as per manufacturer's instructions. Chromatin immunoprecipitation. ChIP-IT Express (Active Motif) was used according to the supplier's recommendations. Cells were crosslinked using 1% formaldehyde for 10 min at room temperature. Formaldehyde was quenched by a 5-min incubation with glycine, cells were rinsed twice with cold PBS, collected by scraping and pelleted at 2,500 r.p.m. for 10 min at 4 uC. Frozen pelleted cells were thawed and re-suspended in lysis buffer, rotated for 30 min at 4 uC, dounced and centrifuged at 5,000 r.p.m. for 10 min at 4 uC. Pelleted nuclei were re-suspended in shearing buffer. Chromatin was then sonicated using a Bioruptor 200 (Diagenode), high frequency, 0.5 min/0.5 min, for 10 min twice. Sonicated chromatin was analysed in 1% agarose gel, to confirm efficient sonication. Input was collected for further analysis. 5-15 mg of chromatin was incubated with 2 mg of rabbit IgG as control (Abcam, ab6742), anti-PADI4 (Sigma, P4749), anti-Klf4 (R&D Systems, AF3158), anti-Oct4 (Santa Cruz Biotechnology, sc-5279X (mouse) or sc-8628X (goat)), anti-Sox2 (Santa Cruz Biotechnology, sc-17320), anti-H3Cit (Abcam, LETTER RESEARCH ab5103), anti-H2A (Abcam, ab18255), anti-H3K4me3 (Millipore, 17-614), anti-RNA polymerase II (Millipore, clone CTD4H8, 05-623) or anti-H1.2 (anti-H1C, a gift from A. Skoultchi) for 1 h at 4 uC and subsequently with protein G magnetic beads. After overnight immunoprecipitation at 4 uC, beads were washed three times with ChIP buffer 1 and two times with ChIP buffer 2. After elution and reverse crosslink (95 uC for 15 min), samples were treated with proteinase K for 1 h. Purified DNA and 1% input were analysed by Fast SYBR green Master Mix qPCR, using serial fourfold dilutions of the concentrated input for standard curves and triplicates per sample. Occupancy is plotted as fold enrichment over input and after subtracting background signal from the beads. Primers are listed in Supplementary  Table 1 . Embryo collection and culture. Embryos were collected into M2 medium (including 4 mg ml 21 BSA) from superovulated C57BL/6 3 CBA females mated with C57BL/6 3 CBA or H2B-EGFP 43 males as previously described 44 . Embryos were cultured in KSOM (including 4 mg ml 21 BSA) under paraffin oil in 5% CO 2 at 37.5 uC. PADI4 inhibitors (Cl-amidine, 10 mM or 200 mM, and TDFA, 100 mM) and HDAC inhibitor (TSA, Sigma, 10 nM) were added to final KSOM from 2-cellstage embryos (44 h after hCG) onwards. The concentration for inhibitors was determined by titration, and was set as the lowest dose that leads to inhibition of enzyme activity and allowed embryonic development to blastocyst stage. No randomization was performed and there was no blinding. Animals were maintained in the Animal Facility of the Gurdon Institute at a 12:12 light cycle and provided with food and water ad libitum. All experiments were conducted in compliance with Home Office regulations.
Immunofluorescence staining and analysis of embryos. Embryos were fixed in 4% PFA for Nanog, Sox17, Cdx2 and H3K9 acetylated staining, and in methanol for H3Cit staining. Immunofluorescence staining was carried out as described previously 45 . Primary antibodies used were as follows: rabbit anti-H3Cit (Abcam, 1:100), rabbit anti-H3K9ac (Upstate, 1:100), rabbit anti-Nanog (Cosmo Bio Co., 1:200), goat anti-Sox17 (R&D systems, 1:200), mouse anti-Cdx2 (Cdx2-88) (Biogenex, 1:200). Secondary antibodies used were AlexaFluor 568-conjugated donkey anti-goat, AlexaFluor 488-conjugated donkey anti-mouse and AlexaFluor 633-conjugated donkey anti-rabbit, and AlexaFluor 488-conjugated anti-rabbit and Texas redconjugated goat anti-rabbit (Invitrogen), at 1:400. Collection of 4-cell embryos and E4.5 blastocysts was performed 56 h and 106 h after hCG, respectively. Confocal microscopy was performed and images analysed using a 40/1.4 NA oil DIC PlanApochromatic lens on an inverted Zeiss 510 Meta confocal microscope. Confocal sections were taken every 2 mm through the whole embryo. To measure the fluorescence levels of H3Cit objectively, individual cells were outlined manually in Image J, and the intensity of the fluorescent signal was recorded for each z-stack (three measurements per nucleus). Only cells in the same z-stacks were compared. Statistical analysis was performed with two-tailed unpaired t-test or MannWhitney U-test (for non-normal distributions). Fluorescence and DIC z-stacks of embryos from late 2-cell (52 h after hCG) to blastocyst stage were collected on 15 focal planes every 15 min for 72 h of continuous embryo culture. The images were processed as described previously 44 . All cells were followed in 4D using SIMI Biocell software (http://www.simi.com/en/products/cell-research/simi-biocell.html/) 46 as previously described 44 . SILAC labelling and mass spectrometry. ES cells were labelled in culture using the Mouse Embryonic Stem Cell SILAC Protein Quantitation kit (Pierce) for at least six passages. Extracted proteins were re-suspended in Laemmli sample buffer, and resolved on a 4-20% SDS-PAGE (NuPAGE, Life Technologies). The gel was stained with Coomassie blue, cut into 20 slices and processed for mass spectrometric analysis using standard in gel procedure 47 . Briefly, cysteines were reduced with dithiothreitol (DTT), alkylated using chloroacetamide (CAA) 48 , and finally the proteins were digested overnight with endoproteinase LysC and loaded onto C18 StageTips before mass spectrometric analysis.
All MS experiments were performed on a nanoscale HPLC system (EASY-nLC from Thermo Scientific) connected to a hybrid LTQ-Orbitrap Velos 49 equipped with a nanoelectrospray source (Thermo Scientific). Each peptide sample was auto-sampled and separated on a 15-cm analytical column (75-cm inner diameter) in-house packed with 3 mm C18 beads (Reprosil Pur-AQ, Dr. Maisch) with a 2 h gradient from 5% to 40% acetonitrile in 0.5% acetic acid. The effluent from the HPLC was directly electrosprayed into the mass spectrometer.
The MS instrument was operated in data-dependent mode to switch between full-scan MS and MS/MS acquisition automatically. Survey full-scan MS spectra (from m/z 300-1,700) were acquired in the Orbitrap mass analyser with resolution R 5 30,000 at m/z 400 (after accumulation to a 'target value' of 1,000,000 in the linear ion trap). The ten most intense peptide ions with charge states $2 were subsequently isolated to a target value of 50,000 using predictive automatic gain control (pAGC) and fragmented by higher-energy collisional dissociation (HCD) in the octopole collision cell using normalized collision energy of 40%. The ion selection threshold was set to 5,000 counts for HCD and the maximum allowed ion accumulation times was set to 500 ms for full scans and 250 ms for HCD. All HCD fragment ion spectra were recorded in the Orbitrap mass analyser with a resolution of 7,500 at m/z 400. For all full-scan measurements, a lock-mass ion from ambient air (m/z 445.120025) was used for internal calibration when present, as described 50 . Identification of peptides and proteins. Mass spectrometry data analysis was performed with the MaxQuant software suite (version 1.2.6.20) as described 51 supported by Andromeda (http://www.maxquant.org) as the database search engine for peptide identifications 52 . We followed the step-by-step protocol of the MaxQuant software suite 53 to generate MS/MS peak lists that were filtered to contain at most six peaks per 100 Da interval and searched by Andromeda against a concatenated target/decoy 54 (forward and reversed) version of the Uniprot human database version (70.101 forward protein entries). Protein sequences of common contaminants such as human keratins and proteases used were added to the database. The initial mass tolerance in MS mode was set to 7 p.p.m. and MS/MS mass tolerance was set to 20 p.p.m. Cysteine carbamidomethylation was searched as a fixed modification, whereas protein N-acetylation, oxidized methionine, deamidation of asparagine and glutamine, and citrullination of arginines were searched as variable modifications. A maximum of two mis-cleavages was allowed whereas we required strict LysC specificity. Peptide assignments were statistically evaluated in a Bayesian model on the basis of sequence length and Andromeda score. We only accepted peptides and proteins with a false discovery rate of less than 1%, estimated on the basis of the number of accepted reverse hits. Native purification of wild-type and mutant linker histone H1.2. Linker histone H1.2 was expressed from a pET 28b (1) vector, provided by the laboratory of R. Schneider. The vector was mutated using Quickchange site-directed mutagenesis protocol (Stratagene) for the expression of R54A and R54K mutants. After transformation into expression strain BL21(DE3)-RIL, pre-cultures were diluted 1:100 into 3 l of LB medium containing kanamycin and camptothecin and grown at 37 uC, 200 r.p.m. At an optical density at 600 nm of 0.6, 0.2 mM IPTG was added and the bacteria grown for another 2 h under the same conditions. Bacterial pellets were collected by centrifugation (15 min, 4,000g, 4 uC), frozen in liquid nitrogen and stored at 280 uC. Linker histone expression was assessed by SDS-PAGE and Coomassie blue stain. Pellets were thawed on ice, re-suspended in 25 ml lysis buffer (20 mM HEPES, pH 7.6; 100 mM NaCl; 5 mM EDTA; 13 complete protease inhibitors (Roche); 1 mM DTT; 0.2 mM PMSF) per litre of culture and lysed through an Avestin high-pressure homogenizer. Lysates were cleared by centrifugation (20,000g, 40 min, 4 uC) and 4 M ammonium sulphate added slowly to the supernatant to a final concentration of 2 M. The mixture was incubated on an endto-end rotator at 4 uC for 20 min before the precipitated proteins were removed by centrifugation (20,000g, 40 min, 4 uC). The supernatant was filtered through a 0.2 mm syringe filter and loaded onto a 20 ml HiPrep 16/10 Phenyl FF (low sub) hydrophobic interaction column (Amersham Biosciences), equilibrated in HEMG buffer (20 mM HEPES, pH 7.6; 50 mM EDTA; 6.25 mM MgCl 2 ; 0.5 mM DTT; 10% glycerol) containing 2 M ammonium sulphate. The sample was injected via a 50-ml super loop at a flow rate of 0.5 ml min
21
, while the flow through, which contained H1.2, was collected in 5-ml fractions. Ten column volumes of HEMG buffer were used to flush the remaining H1.2 from the column. Fractions were analysed by SDS-PAGE and H1.2-containing fractions were pooled and dialysed overnight into HEG buffer (20 mM HEPES, pH 7.6; 50 mM EDTA; 10% glycerol) containing 100 mM NaCl, using 6-8 kDa MWCO dialysis tubing. The protein solution was centrifuged (20,000g, 40 min, 4 uC) to remove precipitated proteins and filtered as above. The solution was loaded onto a 6 ml Resource S column, pre-equilibrated with HEG buffer, and proteins eluted with a gradient of 100 mM to 1 M NaClcontaining HEG buffer (0.5 ml min 21 , 20CV) in 500 ml fractions. Protein fractions were analysed for the presence of H1.2, pooled as above and dialysed in HEG buffer with 100 mM NaCl using dialysis tubing with 10 kDa MWCO. Samples were filtered as above and loaded onto a Mono S column (Amersham Biosciences) equilibrated with HEG buffer containing 100 ml NaCl. 500 ml fractions were collected with a gradient of 100 mM to 1 M NaCl-containing HEG buffer (0.5 ml min 21 , 20CV) and analysed on a 15% SDS-PAGE. Fractions containing H1.2 were pooled, dialysed as above into 50% glycerol and stored at 220 uC. H1-GFP and nucleosome pull-down assays. GFP-tagged linker histone H1.2 (H1.GFP) was expressed in ES cells stably overexpressing human PADI4 or control vector by transfection (Lipofectamine 2000) of a pEGFP-H1.2 vector, containing either the wild-type or the R54A mutant sequence, or with empty pEGFP vector. Transfection efficiency was assessed by visualization of GFP using fluorescence microscopy and determined to be .90%. 24 h after transfection, cells were collected and H1-GFP was pulled down using GFP-TRAP conjugated magnetic beads (Chromotek) as per the manufacturer's instructions, and subjected to immunoblot analysis.
For in vitro nucleosome pull down, nucleosomes containing purified and refolded histone octamers and biotinylated 601 DNA were assembled as described previously 55 and immobilized on Dynabeads Streptavidin MyOne T1 (Invitrogen) for 2 h at 4 uC. Nucleosome-loaded beads in varying amounts were incubated on an end-to-end rotator with wild-type or mutant linker histone H1.2 in binding buffer (20 mM HEPES, pH 7.9; 150 mM NaCl; 0.2 mM EDTA, 20% glycerol; 0.1% NP40; 1 mM DTT, and complete protease inhibitors (Roche)) for 4 h at 4 uC. After five washes in binding buffer, the beads were collected and bound proteins were eluted in sample buffer and subjected to immunoblot analysis. Purification of recombinant PADI4-GST and in vitro deimination assays. Recombinant human PADI4-GST was expressed from pGEX6p constructs in LB Kan media, induced with 0.1 mM IPTG at 25 uC, purified using glutathionesepharose resin, eluted using a 25 mM glutathione solution and stored in 50% glycerol at 220 uC. In vitro deimination of linker histone H1.2 was carried out in deimination buffer (50 mM HEPES, pH 7.5; 2 mM DTT; in the presence or absence of 10 mM CaCl 2 ) at 37 uC for 1 h, using the active enzyme. Samples were re-suspended in sample buffer for immunoblot analysis.
Treatment of permeabilized cells with recombinant PADI4. Cells were resuspended in a cold solution of 80 mg ml 21 digitonin in SuNaSP 56 , mixed gently but thoroughly and incubated on ice for 3 min. Complete permeabilization was checked by Trypan blue uptake of sub-aliquots of the suspension and the reaction was stopped by addition of SuNaSP containing 3% BSA. Permeabilized cells were then pre-incubated in wash buffer (20 mM HEPES-KOH, 75 mM KCl, 1.5 mM MgCl 2 , 5 mM CaCl 2 ) with 0.2% Triton X-100 for 30 min at 37 uC. Nuclei were washed in wash buffer and incubated in reaction buffer (20 mM HEPES-KOH, 75 mM KCl, 1.5 mM MgCl 2 , 5 mM CaCl 2, 2 mM DTT) with or without recombinant PADI4 for 1.5 h at 37 uC. The nuclei were washed several times in wash buffer to remove excess PADI4 and released proteins that were not stably bound within the nucleus. The 'Washes' fraction contains all proteins that are no longer stably bound, including recombinant human PADI4. The 'Pellet' contains all other nuclear-retained proteins. The wash supernatants were concentrated by trichloroacetic acid protein precipitation and subjected to immunoblot analysis. The washed nuclei were washed a further time in PBS for immunoblot analysis or in MNase buffer and used for DNA compaction assays. Micrococcal nuclease digestion. Cell pellets were washed twice and re-suspended in micrococcal nuclease (MNase) buffer (15 mM Tris, pH 7.5; 15 mM NaCl; 60 mM KCl; 0.34 M sucrose; 0.5 mM spermidine; 0.15 mM spermine; 0.25 mM PMSF; 0.1% b-mercaptoethanol). 1 mM of CaCl 2 was added and the suspension was divided into equal aliquots, which were kept on ice. MNase was added to a final concentration of 0.5 U ml 21 and samples were incubated at 25 uC in a heat block for varying amounts of time. The reaction was stopped by addition of 0.5 M EDTA and 0.5 M EGTA and DNA purified using a QIAGEN PCR purification kit. DNA was quantified and 1,500 ng of each sample was loaded on a 1.5% agarose gel containing ethidium bromide. c, Immunoblot analysis of H3Cit levels in ES, NSO4G and iPS cells. Total H3 is presented as a loading control. d, Immunoblot analysis of total citrullination levels in ES, NSO4G and iPS cells, using an antibody against modified citrulline (ModCit), which recognizes peptidylcitrulline irrespective of amino acid sequence. Total H3 is presented as a loading control. e, ZHBTc4.1 and 2TS22C ES cell lines were treated with 1 mg ml 21 doxycycline for 48 h, resulting in depletion of Oct4 or Sox2 (data not shown). Padi4 mRNA was significantly reduced on Oct4, but not Sox2 knockdown, as assessed by qPCR. Error bars represent standard error of the mean of four biological replicates. f, ChIP-qPCR for Oct4, Sox2, Klf4, RNA polymerase II (PolII), H3K4me3 and H2A on the promoter of Padi4 in mouse ES and NSO4G cells. For each cell condition, the signal is presented as fold enrichment over input and after subtracting background signal from the beads. Error bars represent the standard deviation of three technical qPCR replicates. Asterisks denote difference with ES cells (a) or ES media (b), and 0 h time point (e); NS, not significant, *P # 0.05, **P # 0.01, ***P # 0.001, ****P # 0.0001 by ANOVA (a) or t-test (b, e). and H3Cit at pluripotency loci. a, Representative ChIP-qPCR for H2A on regulatory regions of Tcl1 and Nanog in mouse ES, NSO4G and iPS cells (corresponding to Fig. 1h ). For each cell condition, the signal is presented as fold enrichment over input and after subtracting background signal from the beads. Error bars represent the standard deviation of three technical qPCR replicates. b, ChIP-qPCR for human PADI4 on regulatory regions of Tcl1, Nanog, Klf2 and Kit, which are upregulated by human PADI4 overexpression, in mouse ES cells stably expressing human PADI4. For each cell condition, the signal is presented as fold enrichment over input and after subtracting background signal from the beads. Enhancer regions for Kit located 13. UbC. Error bars presented as standard error of the mean of three biological replicates. Asterisks denote difference with Ctrl; *P # 0.05, **P # 0.01, ****P # 0.0001 by t-test. c, Gene Ontology for Biological Process (GOBP) analysis for the most regulated gene categories within the microarray data set of Cl-amidine treatment in mouse ES cells. P value is corrected for multiple testing using Benjamini-Hochberg FDR. Table with quantifications of lineage commitment in E4.5 blastocysts treated with 10 mM Cl-amidine from the 2-cell stage. Asterisks denote difference with control, unpaired t-test; *P , 0.05; n 5 3 (50 embryos). e, Embryos were cultured in medium supplemented with 10 mM Cl-amidine from 2-cell stage and through pre-implantation development. E4.5 blastocysts were fixed and stained for Sox17 (primitive endoderm marker, red), Cdx2 (trophectoderm marker, green) and Hoechst 33342 (blue). Scale bar, 20 mm. f, Time-lapse analysis of distribution of inner and outer cells at the 8-16-cell transition, on culturing of embryos with medium containing 10 mM Cl-amidine from 2-cell stage. Error bars represent standard error of the mean. Statistical significance was determined by unpaired t-test or Mann-Whitney U-test upon non-normal distribution. Asterisks denote difference with control; *P # 0.05. Asterisks denote difference with control, unpaired t-test; *P , 0.05; n 5 2 (32 embryos). c, Embryos at 2-cell stage were treated with 10 nM TSA and fixed at embryonic day E4.5. Phase contrast, Nanog (green), Sox17 (purple), Cdx2 (red) and Hoechst 33342 (blue) images are shown.
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